Please assess the completion status of the following clinical trial:

Trial Title: Randomized, Double-Blind, Placebo-Controlled Study Of Pregabalin In Patients With Fibromyalgia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* ACR criteria for fibromyalgia~* A score of more or equal to 40 mm on the Pain VAS~* An average score more or equal to 4 on 4 daily pain diaries~Exclusion Criteria:~* Patients with other severe pain conditions~* Patients with severe depression~* Patients taking excluded medications~* Patients with suicidality

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Placebo (Type: PLACEBO_COMPARATOR): None
- Pregabalin (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).